Skip to main content
ILLUMINA, INC. logo

ILLUMINA, INC. — Investor Relations & Filings

Ticker · ILMN ISIN · US4523271090 LEI · SQ95QG8SR5Q56LSNF682 US Manufacturing
Open in API
Filings indexed 2,572 across all filing types
Latest filing 2022-04-07 Director's Dealing
Country US United States of America
Listing US ILMN

About ILLUMINA, INC.

https://www.illumina.com

Illumina, Inc. develops, manufactures, and markets integrated systems for the analysis of genetic variation and biological function. The company is a provider of DNA sequencing and array-based technologies. Its portfolio includes next-generation sequencing (NGS) platforms, microarrays, library preparation kits, and bioinformatics software. These products and services are utilized by researchers and clinicians for applications in life science research, translational and consumer genomics, molecular diagnostics, oncology, and reproductive health. The company's solutions are designed to advance genomic discoveries and enable precision medicine by providing tools for DNA, RNA, and protein analysis.

Recent filings

Filing Released Lang Actions
PRIMARY DOCUMENT
Director's Dealing
2022-04-07 English
PRIMARY DOCUMENT
Director's Dealing
2022-03-31 English
PRE 14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is titled 'PRE 14A' and is identified as a 'Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934.' It includes detailed information about the annual meeting of stockholders, including the date, agenda items such as election of directors, ratification of auditors, advisory votes on executive compensation, and amendments to the certificate of incorporation. It also contains extensive information about the board of directors, corporate governance, executive compensation, and voting instructions. The document is clearly a proxy statement intended to solicit shareholder votes for the annual meeting. This matches the definition of Proxy Solicitation & Information Statement (PSI). The document length (15,000 characters) and content confirm it is the full proxy statement, not just an announcement or summary. Therefore, the correct classification is PSI with high confidence.
2022-03-29 English
PRIMARY DOCUMENT
Director's Dealing
2022-03-21 English
PRIMARY DOCUMENT
Director's Dealing
2022-03-04 English
PRIMARY DOCUMENT
Director's Dealing
2022-03-04 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.